Gayle Crowell's most recent trade in Pliant Therapeutics Inc was a trade of 70,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pliant Therapeutics Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Hercules Cap Inc | Gayle Crowell | Director | Purchase of securities on an exchange or from another person at price $ 14.35 per share. | 26 Mar 2026 | 7,317 | 97,589 (0%) | 0% | 14.4 | 104,999 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Purchase of securities on an exchange or from another person at price $ 15.20 per share. | 23 Feb 2026 | 6,600 | 87,458 (0%) | 0% | 15.2 | 100,320 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Purchase of securities on an exchange or from another person at price $ 17.77 per share. | 03 Nov 2025 | 6,000 | 78,727 (0%) | 0% | 17.8 | 106,647 | Common Stock |
| Pliant Therapeutics Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 30,000 | 30,000 | - | - | Common Stock (Right to Buy) | |
| Hercules Cap Inc | Gayle Crowell | Director | Purchase of securities on an exchange or from another person at price $ 17.49 per share. | 08 May 2025 | 5,999 | 69,344 (0%) | 0% | 17.5 | 104,923 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Purchase of securities on an exchange or from another person at price $ 18.06 per share. | 06 Aug 2024 | 5,790 | 59,366 (0%) | 0% | 18.1 | 104,592 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Purchase of securities on an exchange or from another person at price $ 20.07 per share. | 25 Jun 2024 | 701 | 53,576 (0%) | 0% | 20.1 | 14,067 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 19.80 per share. | 20 Jun 2024 | 3,030 | 52,874 (0%) | 0% | 19.8 | 59,994 | Common Stock |
| Pliant Therapeutics Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 26,764 | 26,764 | - | - | Common Stock (Right to Buy) | |
| Envestnet Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 3,987 | 17,075 (0%) | 0% | 0 | Common Stock | |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 15.72 per share. | 22 Nov 2023 | 1,051 | 47,740 (0%) | 0% | 15.7 | 16,522 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 15.87 per share. | 22 Nov 2023 | 149 | 46,689 (0%) | 0% | 15.9 | 2,365 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 15.90 per share. | 08 Sep 2023 | 5,656 | 46,540 (0%) | 0% | 15.9 | 89,930 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 16.44 per share. | 25 Aug 2023 | 812 | 40,884 (0%) | 0% | 16.4 | 13,349 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 16.41 per share. | 25 Aug 2023 | 144 | 40,072 (0%) | 0% | 16.4 | 2,363 | Common Stock |
| Pliant Therapeutics Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) | |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 13.87 per share. | 23 May 2023 | 865 | 39,928 (0%) | 0% | 13.9 | 11,998 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 13.09 per share. | 23 May 2023 | 218 | 39,063 (0%) | 0% | 13.1 | 2,854 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Purchase of securities on an exchange or from another person at price $ 13.66 per share. | 08 May 2023 | 7,200 | 38,845 (0%) | 0% | 13.7 | 98,352 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 15.33 per share. | 09 Mar 2023 | 755 | 31,645 (0%) | 0% | 15.3 | 11,574 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 15.32 per share. | 09 Mar 2023 | 187 | 30,890 (0%) | 0% | 15.3 | 2,865 | Common Stock |
| Envestnet Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 3,208 | 13,088 (0%) | 0% | 0 | Common Stock | |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 14.32 per share. | 17 Nov 2022 | 839 | 30,703 (0%) | 0% | 14.3 | 12,014 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 14.06 per share. | 17 Nov 2022 | 220 | 29,863 (0%) | 0% | 14.1 | 3,093 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 15.76 per share. | 16 Aug 2022 | 718 | 29,643 (0%) | 0% | 15.8 | 11,316 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 15.13 per share. | 16 Aug 2022 | 201 | 28,925 (0%) | 0% | 15.1 | 3,041 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 16.13 per share. | 01 Aug 2022 | 4,339 | 28,724 (0%) | 0% | 16.1 | 69,996 | Common Stock |
| Pliant Therapeutics Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 13.82 per share. | 24 May 2022 | 799 | 24,385 (0%) | 0% | 13.8 | 11,042 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 17.17 per share. | 16 Mar 2022 | 643 | 23,586 (0%) | 0% | 17.2 | 11,040 | Common Stock |
| Envestnet Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 2,352 | 9,880 (0%) | 0% | 0 | Common Stock | |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 17.33 per share. | 17 Nov 2021 | 521 | 22,942 (0%) | 0% | 17.3 | 9,029 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 16.98 per share. | 18 Aug 2021 | 498 | 22,421 (0%) | 0% | 17.0 | 8,456 | Common Stock |
| Hercules Cap Inc | Gayle Crowell | Director | Grant, award, or other acquisition of securities at price $ 17.44 per share. | 02 Aug 2021 | 4,013 | 21,923 (0%) | 0% | 17.4 | 69,987 | Common Stock |